drugset / Trial / NCT00224289

Effect of Age on Latanoprost 0.005% in Patients With Glaucoma

NCT00224289

Phase 4 Completed 17 enrolled Yale University Pfizer · collab
NaSingle-groupOpen-labelTreatment

Summary

Latanoprost is a commonly used treatment for glaucoma. Because of its mechanism of action, it is plausible that the age of a patient using the medication may affect its efficacy and time of onset. We are going to study the effectiveness of Latanoprost in people of different ages, to see if it changes based on the age of the patient.

Timeline

Start
2005-03
Primary completion
2009-04
Completion
2009-04

Drugs

EvaluationDrugModalityDoseRoute
Subject Latanoprost Small molecule 0.005 % Topical

Indications